Anti-SARAF monoclonal antibody

Pre-made anti-SARAF monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SARAF/SARAF products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2119-Ab-1/ GM-Tg-hg-IP2119-Ab-2Anti-Human SARAF monoclonal antibodyHuman
GM-Tg-rg-IP2119-Ab-1/ GM-Tg-rg-IP2119-Ab-2Anti-Rat SARAF monoclonal antibodyRat
GM-Tg-mg-IP2119-Ab-1/ GM-Tg-mg-IP2119-Ab-2Anti-Mouse SARAF monoclonal antibodyMouse
GM-Tg-cynog-IP2119-Ab-1/ GM-Tg-cynog-IP2119-Ab-2Anti-Cynomolgus/ Rhesus macaque SARAF monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2119-Ab-1/ GM-Tg-felg-IP2119-Ab-2Anti-Feline SARAF monoclonal antibodyFeline
GM-Tg-cang-IP2119-Ab-1/ GM-Tg-cang-IP2119-Ab-2Anti-Canine SARAF monoclonal antibodyCanine
GM-Tg-bovg-IP2119-Ab-1/ GM-Tg-bovg-IP2119-Ab-2Anti-Bovine SARAF monoclonal antibodyBovine
GM-Tg-equg-IP2119-Ab-1/ GM-Tg-equg-IP2119-Ab-2Anti-Equine SARAF monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2119-Ab-1/ GM-Tg-hg-IP2119-Ab-2; GM-Tg-rg-IP2119-Ab-1/ GM-Tg-rg-IP2119-Ab-2;
GM-Tg-mg-IP2119-Ab-1/ GM-Tg-mg-IP2119-Ab-2; GM-Tg-cynog-IP2119-Ab-1/ GM-Tg-cynog-IP2119-Ab-2;
GM-Tg-felg-IP2119-Ab-1/ GM-Tg-felg-IP2119-Ab-2; GM-Tg-cang-IP2119-Ab-1/ GM-Tg-cang-IP2119-Ab-2;
GM-Tg-bovg-IP2119-Ab-1/ GM-Tg-bovg-IP2119-Ab-2; GM-Tg-equg-IP2119-Ab-1/ GM-Tg-equg-IP2119-Ab-2
Products NameAnti-SARAF monoclonal antibody
Formatmab
Target NameSARAF
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SARAF monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2119-Ag-1Recombinant multi-species SARAF/ FOAP-7/ HSPC035 protein
    ORF Viral VectorpGMLP002260human SARAF Lentivirus plasmid
    ORF Viral VectorvGMLP002260human SARAF Lentivirus particle
    ORF Viral VectorpGMLPm002846mouse Saraf Lentivirus plasmid
    ORF Viral VectorvGMLPm002846mouse Saraf Lentivirus particle


    Target information

    Target IDGM-IP2119
    Target NameSARAF
    Gene ID51669,67887,290796,693452,482878,101089096,515461,100062785
    Gene Symbol and Synonyms1810045K07Rik,FOAP-7,HSPC035,SARAF,™EM66,XTP3
    Uniprot AccessionQ96BY9,Q6AYN2,Q08E24
    Uniprot Entry NameSARAF_HUMAN,SARAF_RAT,SARAF_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000133872
    Target ClassificationN/A

    The target: SARAF, gene name: SARAF, also named as FOAP-7, HSPC035, ™EM66, XTP3. Involved in regulation of store-operated calcium entry. Located in endoplasmic reticulum and endoplasmic reticulum-plasma membrane contact site. Is integral component of endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.